Peter J
No ORCID on file
· 1 paper in corpus
other
2022
BACKGROUND: The Janssen-Ad26.COV2.S vaccine is authorized for use in several countries, with more than 30 million doses administered. Mild and severe allergic adverse events following immunization (AEFI) have been reported. OBJECTIVE: We s…